CIDARA THERAPEUTICS INC's ticker is CDTX and the CUSIP is 171757107. A total of 55 filers reported holding CIDARA THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $148,000 | -94.6% | 73,351 | -92.4% | 0.02% | -95.4% |
| Q3 2020 | $2,766,000 | -22.8% | 970,664 | 0.0% | 0.54% | -25.2% |
| Q2 2020 | $3,582,000 | +59.4% | 970,664 | +7.1% | 0.72% | +21.5% |
| Q1 2020 | $2,247,000 | -15.2% | 906,056 | -9.4% | 0.60% | -18.9% |
| Q1 2019 | $2,650,000 | -6.0% | 1,000,000 | -16.7% | 0.73% | -30.2% |
| Q4 2018 | $2,820,000 | -46.6% | 1,200,000 | 0.0% | 1.05% | -21.7% |
| Q3 2018 | $5,280,000 | -15.4% | 1,200,000 | 0.0% | 1.34% | -16.8% |
| Q2 2018 | $6,240,000 | +553.4% | 1,200,000 | +879.6% | 1.62% | +240.0% |
| Q1 2017 | $955,000 | +115.6% | 122,500 | +184.9% | 0.48% | +60.5% |
| Q2 2016 | $443,000 | – | 43,000 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,356,813 | $3,189,000 | 4.48% |
| Omega Fund Management, LLC | 1,508,794 | $3,546,000 | 2.63% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 482,357 | $1,134,000 | 1.65% |
| Opaleye Management Inc. | 1,200,000 | $2,820,000 | 1.05% |
| BVF INC/IL | 2,904,684 | $6,826,000 | 0.89% |
| FRAZIER MANAGEMENT LLC | 1,312,258 | $3,084,000 | 0.80% |
| Monashee Investment Management LLC | 480,851 | $1,130,000 | 0.76% |
| Aisling Capital LLC | 1,021,148 | $2,400,000 | 0.68% |
| Trellus Management Company, LLC | 94,143 | $221,000 | 0.50% |
| Prosight Management, LP | 245,764 | $578,000 | 0.30% |